Jean-Sélim Driouich

7PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsMedical infection agents (incl. prions)Pharmaceutical delivery technologiesCheminformatics and quantitative structure-activity relationshipsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2026
Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

|Jan 14, 2026
Modulating Chikungunya and Mayaro virus-induced disease severity in mice using low concentrations of anti-IFNAR1 antibodies.

Konrad Wesselmann, Léa Luciani, Gregory Moureau

|Aug 26, 2022
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.

Frauke Assmus, Jean-Sélim Driouich, Rana Abdelnabi

|Mar 20, 2021
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.

Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas

|Jul 24, 2019
Reverse Genetics of RNA Viruses: ISA-Based Approach to Control Viral Population Diversity without Modifying Virus Phenotype.

Jean-Sélim Driouich, Gregory Moureau, Xavier de Lamballerie

|May 31, 2019
An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.

Ludek Eyer, Antoine Nougairède, Marie Uhlířová

Pageof 2

Frequent Collaborators

4 joint publications

Xavier de Lamballerie

3 joint publications

Franck Touret

3 joint publications

Antoine Nougairède

2 joint publications

Jérémie Guedj